Buy Cipla, target price Rs 1140: Emkay Global
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 73115.08 Crore) operating in Pharmaceuticals sector.

Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 73115.08 Crore) operating in Pharmaceuticals sector.
Cipla Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives, Royalty Income and Scrap for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company reported a Consolidated Total Income of Rs 5580.47 Crore, up .20 % from last quarter Total Income of Rs 5569.28 Crore and up 9.60 % from last year same quarter Total Income of Rs 5091.76 Crore. Company reported net profit after tax of Rs 712.00 Crore in latest quarter.
Promoter/FII Holdings
Promoters held 36.12 per cent stake in the company as of 30-Sep-2021, while FIIs owned 28.1 per cent, DIIs 17.74 per cent.
Download ET Markets APP